Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (21-30 of 394) with videos related to

Pageof 40
Sort By:
Gastroenterology|May 1, 2026
Reply to Xu et al, Ni and Wang, Parikh and Singal, and Yang et alGrishma Hirode, Jordan J Feld
Journal of Hepatology|February 16, 2021
Remaining challenges in HCV eliminationCamelia Capraru, Jordan J Feld
Gastroenterology|September 5, 2017
Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?Raoel Maan, Jordan J Feld
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2017
Overcoming the resistance to resistance testing: Collecting the dataAdam Doyle, Jordan J Feld
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 26, 2015
Hepatitis C virus infectionMichael Fralick, Jordan J Feld
Current Opinion in Rheumatology|May 21, 2014
Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agentsJoshua Juan, Jordan J Feld
Gastroenterology|October 28, 2018
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?George N Ioannou, Jordan J Feld
Nature|August 19, 2005
Mechanism of action of interferon and ribavirin in treatment of hepatitis CJordan J Feld, Jay H Hoofnagle
Hepatology (Baltimore, Md.)|February 16, 2020
Letter to the Editor: Safety First: Favoring Prophylactic/Preemptive Over Delayed Treatment in D+/R- TransplantsNorah A Terrault, Jordan J Feld
Nature Reviews. Gastroenterology & Hepatology|January 9, 2019
Host-pathogen interactions in chronic HBV infection and transplantation of HCV-positive organsJordan J Feld, Adam J Gehring
Pageof 40

Showing results (21-30 of 394) with videos related to

Sort By:
Pageof 40
Gastroenterology|May 1, 2026
Reply to Xu et al, Ni and Wang, Parikh and Singal, and Yang et alGrishma Hirode, Jordan J Feld
Journal of Hepatology|February 16, 2021
Remaining challenges in HCV eliminationCamelia Capraru, Jordan J Feld
Gastroenterology|September 5, 2017
Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?Raoel Maan, Jordan J Feld
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2017
Overcoming the resistance to resistance testing: Collecting the dataAdam Doyle, Jordan J Feld
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 26, 2015
Hepatitis C virus infectionMichael Fralick, Jordan J Feld
Current Opinion in Rheumatology|May 21, 2014
Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agentsJoshua Juan, Jordan J Feld
Gastroenterology|October 28, 2018
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?George N Ioannou, Jordan J Feld
Nature|August 19, 2005
Mechanism of action of interferon and ribavirin in treatment of hepatitis CJordan J Feld, Jay H Hoofnagle
Hepatology (Baltimore, Md.)|February 16, 2020
Letter to the Editor: Safety First: Favoring Prophylactic/Preemptive Over Delayed Treatment in D+/R- TransplantsNorah A Terrault, Jordan J Feld
Nature Reviews. Gastroenterology & Hepatology|January 9, 2019
Host-pathogen interactions in chronic HBV infection and transplantation of HCV-positive organsJordan J Feld, Adam J Gehring
Pageof 40